KuartisMED ^None

KuartisMED is a biomedical company that focuses on developing innovative products for the healthcare and well-being of preterm infants. Their flagship product, Premades, is a monitoring system that helps assess feeding ability in newborns. The company has received grants from the European Union's Horizon 2020 research and innovation program, including a Phase-2 grant for new business models for inclusive, innovative, and reflective societies. KuartisMED received a Phase-1 grant in 2014 for the feasibility study and commercialization plan for Premades.